IN8bio, Inc. (INAB) Income Annual - Discounting Cash Flows
INAB
IN8bio, Inc.
INAB (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2024
12-31
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
Report Filing 2025-11-06 2025-03-13 2024-03-14 2023-03-30 2022-03-17 2020-12-31 2019-12-31 2018-12-31
Revenue 0 0 0 0 0 0 0 0
Cost of Revenue 0 0 2.5 0 0 0 0.096 0.096
Gross Profit 0 0 -2.5 0 0 0 -0.096 -0.096
Operating Expenses 20.66 30.44 27.84 28.52 14.65 8.56 5.04 1.91
Research & Development 11.16 16.96 16.83 14.06 7.35 5.38 2.36 0.581
Selling, General and Administrative 9.89 12.64 13.51 14.46 7.31 3.18 2.71 1.42
Other Operating Expenses -0.394 0.838 -2.5 0 0 0 -0.028 -0.096
Operating Income -20.66 -30.44 -30.34 -28.52 -14.65 -8.56 -5.13 -2
Net Non-Operating Interest 0.394 0.23 0 0 0 0 0 -0.014
Interest Income 0.394 0.23 0 0 0 0 0 0
Interest Expense 0 0 0 0 0 0 0 0.014
Equity & Other Income/(Expense) -0.394 -0.23 0.33 0 0 0 0 -0.063
Income Before Tax -20.66 -30.44 -30.01 -28.52 -14.65 -8.56 -5.13 -2.08
Income Tax Expense 0 0 0 0 0 0 0 0
Income Attributable to Non-Controlling Interest 0 0 0 0 0 0 0 0
Net Income -20.66 -30.44 -30.01 -28.52 -14.65 -8.56 -5.13 -2.08
Depreciation and Amortization 2.68 2.65 2.5 1.1 0.788 0.088 0.096 0.096
EBITDA -17.98 -27.78 -27.84 -27.42 -13.87 -8.47 -5.04 -1.91
Earnings Per Share (EPS) -2.24 -0.57 -1 -1.36 -0.78 -0.53 -0.27 -0.11
Diluted Earnings Per Share -2.24 -0.57 -1 -1.36 -0.78 -0.53 -0.27 -0.11
Weighted Average Shares Outstanding 4.54 53.55 29.86 20.97 18.78 19.35 19.35 19.35
Diluted Weighted Average Shares Outstanding 4.54 53.55 29.86 20.97 18.78 19.35 19.35 19.35
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program